Association between polymorphic variation in VDR and RXRA and circulating levels of vitamin D metabolites

Journal of Steroid Biochemistry and Molecular Biology

Volumn 121, Issue 1-2, 2010, Pages 438-441

  Hibler, E A ^a,b   Jurutka, P W ^c,d   Egan, J B ^b   Hu, C ^a   LeRoy, E C ^b   Martinez, M E ^a,b   Thompson, P A ^a,b   Jacobs, E T ^a,b  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c ARIZONA STATE UNIVERSITY WEST   (United States)

^d UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

1,25(OH)2D; 25(OH)D; Polymorphism; RXR; VDR; Vitamin D

Indexed keywords

1,25 DIHYDROXYERGOCALCIFEROL; RETINOID X RECEPTOR ALPHA; VITAMIN D RECEPTOR; BIOLOGICAL MARKER; CALCIFEDIOL; CALCITRIOL; CALCITRIOL RECEPTOR; VITAMIN D;

ALLELE; ARTICLE; GENETIC VARIABILITY; GENOTYPE; HUMAN; SINGLE NUCLEOTIDE POLYMORPHISM; BIOLOGICAL MODEL; BLOOD; GENETIC POLYMORPHISM; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; PRINCIPAL COMPONENT ANALYSIS;

BIOLOGICAL MARKERS; CALCIFEDIOL; CALCITRIOL; GENETIC VARIATION; GENOTYPE; HUMANS; MODELS, BIOLOGICAL; MODELS, GENETIC; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PRINCIPAL COMPONENT ANALYSIS; RECEPTORS, CALCITRIOL; RETINOID X RECEPTOR ALPHA; TRANSCRIPTION, GENETIC; VITAMIN D;

EID: 77954760449     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2010.03.052     Document Type: Article

References (37)

1. Anderson P., May B., Morris H. Vitamin d metabolism: new concepts and clinical implications. Clin. Biochem. Rev. 2003, 24(1):13-26.
2. Dixon K.M., Mason R.S. Vitamin D. Int. J. Biochem. Cell Biol. 2009, 41(5):982-985.
3. Holick M.F. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am. J. Clin. Nutr. 2004, 80(6 Suppl.):1678S-1688S.
4. Norman A.W. From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health. Am. J. Clin. Nutr. 2008, 88(2):491S-499S.
5. Dusso A.S., Brown A.J., Slatopolsky E. Vitamin D. Am. J. Physiol. Renal Physiol. 2005, 289(1):F8-F28.
6. Wolpowitz D., Gilchrest B.A. The vitamin D questions: how much do you need and how should you get it?. J. Am. Acad. Dermatol. 2006, 54(2):301-317.
7. DeLuca H.F., Cantorna M.T. Vitamin D: its role and uses in immunology. FASEB J. 2001, 15(14):2579-2585.
8. 2D: emergence as clinically important diagnostic tools. Nutr. Rev. 2007, 65(8 Pt 2):S87-S90.
9. Yee Y.K., Chintalacharuvu S.R., Lu J., Nagpal S. Vitamin D receptor modulators for inflammation and cancer. Mini Rev. Med. Chem. 2005, 5(8):761-778.
10. P. MacDonald, Molecular biology of the vitamin D receptor, in: M.F. Holick (Ed.), Vitamin D: Physiology, Molecular Biology, and Clinical Applications, Totowa, NJ, 1999, pp. 109-128.
11. Haussler M.R., Haussler C.A., Bartik L., Whitfield G.K., Hsieh J.C., Slater S., Jurutka P.W. Vitamin D receptor: molecular signaling and actions of nutritional ligands in disease prevention. Nutr. Rev. 2008, 66(10 Suppl. 2):S98-S112.
12. Bastien J., Rochette-Egly C. Nuclear retinoid receptors and the transcription of retinoid-target genes. Gene 2004, 328:1-16.
13. Qin S., Okawa Y., Atangan L.I., Brown G., Chandraratna R.A., Zhao Y. Integrities of A/B and C domains of RXR are required for rexinoid-induced caspase activations and apoptosis. J. Steroid Biochem. Mol. Biol. 2008, 112(1-3):25-31.
14. Szanto A., Narkar V., Shen Q., Uray I.P., Davies P.J., Nagy L. Retinoid X receptors: X-ploring their (patho)physiological functions. Cell Death Differ. 2004, 11 Suppl. 2:S126-S143.
15. de Lera A.R., Bourguet W., Altucci L., Gronemeyer H. Design of selective nuclear receptor modulators: RAR and RXR as a case study. Nat. Rev. Drug Discov. 2007, 6(10):811-820.
16. Alberts D.S., Martinez M.E., Hess L.M., Einspahr J.G., Green S.B., Bhattacharyya A.K., Guillen J., Krutzsch M., Batta A.K., Salen G., Fales L., Koonce K., Parish D., Clouser M., Roe D., Lance P. Phase III trial of ursodeoxycholic acid to prevent colorectal adenoma recurrence. J. Natl. Cancer Inst. 2005, 97(11):846-853.
17. Desreumaux P., Dubuquoy L., Nutten S., Peuchmaur M., Englaro W., Schoonjans K., Derijard B., Desvergne B., Wahli W., Chambon P., Leibowitz M.D., Colombel J.F., Auwerx J. Attenuation of colon inflammation through activators of the retinoid X receptor (RXR)/peroxisome proliferator-activated receptor gamma (PPARgamma) heterodimer. A basis for new therapeutic strategies. J. Exp. Med. 2001, 193(7):827-838.
18. Fan Y.Y., Spencer T.E., Wang N., Moyer M.P., Chapkin R.S. Chemopreventive n-3 fatty acids activate RXRalpha in colonocytes. Carcinogenesis 2003, 24(9):1541-1548.
19. Yamazaki K., Shimizu M., Okuno M., Matsushima-Nishiwaki R., Kanemura N., Araki H., Tsurumi H., Kojima S., Weinstein I.B., Moriwaki H. Synergistic effects of RXR alpha and PPAR gamma ligands to inhibit growth in human colon cancer cells-phosphorylated RXR alpha is a critical target for colon cancer management. Gut 2007, 56(11):1557-1563.
20. Jacobs E.T., Alberts D.S., Benuzillo J., Hollis B.W., Thompson P.A., Martinez M.E. Serum 25(OH)D levels, dietary intake of vitamin D, and colorectal adenoma recurrence. J. Steroid Biochem. Mol. Biol. 2007, 103(3-5):752-756.
21. Levine A.J., Figueiredo J.C., Won L., Poynter J.N., Conti D., Duggan D.J., Campbell P.T., Newcomb P., Martinez M.E., Hopper J.L., Marchand L.L., Baron J.A., Limburg P.J., Haile R.W. Genetic variability in the MTHFR gene and colorectal cancer risk in the Colorectal Cancer Family Registry. Cancer Epidemiol. Biomarkers Prev. 2009, 19(1):89-100.
22. 125I-labeled tracer. Clin. Chem. 1993, 39(3):529-533.
23. Hollis B.W. Assay of circulating 1,25-dihydroxyvitamin D involving a novel single-cartridge extraction and purification procedure. Clin. Chem. 1986, 32(11):2060-2063.
24. Jacobs E.T., Alberts D.S., Foote J.A., Green S.B., Hollis B.W., Yu Z., Martinez M.E. Vitamin D insufficiency in southern Arizona. Am. J. Clin. Nutr. 2008, 87(3):608-613.
25. Gauderman W.J., Murcray C., Gilliland F., Conti D.V. Testing association between disease and multiple SNPs in a candidate gene. Genet. Epidemiol. 2007, 31(5):383-395.
26. Conneely K.N., Boehnke M. So many correlated tests, so little time! Rapid adjustment of P values for multiple correlated tests. Am. J. Hum. Genet. 2007, 81(6).
27. Kostner K., Denzer N., Muller C.S., Klein R., Tilgen W., Reichrath J. The relevance of vitamin D receptor (VDR) gene polymorphisms for cancer: a review of the literature. Anticancer Res. 2009, 29(9):3511-3536.
28. Ma J., Stampfer M.J., Gann P.H., Hough H.L., Giovannucci E., Kelsey K.T., Hennekens C.H., Hunter D.J. Vitamin D receptor polymorphisms, circulating vitamin D metabolites, and risk of prostate cancer in United States physicians. Cancer Epidemiol. Biomarkers Prev. 1998, 7(5):385-390.
29. Morrison N.A., Qi J.C., Tokita A., Kelly P.J., Crofts L., Nguyen T.V., Sambrook P.N., Eisman J.A. Prediction of bone density from vitamin D receptor alleles. Nature 1994, 367(6460):284-287.
30. Ahn J., Albanes D., Berndt S.I., Peters U., Chatterjee N., Freedman N.D., Abnet C.C., Huang W.Y., Kibel A.S., Crawford E.D., Weinstein S.J., Chanock S.J., Schatzkin A., Hayes R.B. Vitamin D-related genes, serum vitamin D concentrations and prostate cancer risk. Carcinogenesis 2009, 30(5):769-776.
31. Lowe L.C., Guy M., Mansi J.L., Peckitt C., Bliss J., Wilson R.G., Colston K.W. Plasma 25-hydroxy vitamin D concentrations, vitamin D receptor genotype and breast cancer risk in a UK Caucasian population. Eur. J. Cancer 2005, 41(8):1164-1169.
32. Mikhak B., Hunter D.J., Spiegelman D., Platz E.A., Hollis B.W., Giovannucci E. Vitamin D receptor (VDR) gene polymorphisms and haplotypes, interactions with plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D, and prostate cancer risk. Prostate 2007, 67(9):911-923.
33. Wjst M., Altmuller J., Faus-Kessler T., Braig C., Bahnweg M., Andre E. Asthma families show transmission disequilibrium of gene variants in the vitamin D metabolism and signalling pathway. Respir. Res. 2006, 7:60.
34. Chang S.C., Rashid A., Gao Y.T., Andreotti G., Shen M.C., Wang B.S., Han T.Q., Zhang B.H., Sakoda L.C., Leitzmann M.F., Chen B.E., Rosenberg P.S., Chen J., Chanock S.J., Hsing A.W. Polymorphism of genes related to insulin sensitivity and the risk of biliary tract cancer and biliary stone: a population-based case-control study in Shanghai, China. Carcinogenesis 2008, 29(5):944-948.
35. Zierold C., Darwish H.M., DeLuca H.F. Two vitamin D response elements function in the rat 1,25-dihydroxyvitamin D 24-hydroxylase promoter. J. Biol. Chem. 1995, 270(4):1675-1678.
36. NCBI, Reference SNP(refSNP) Cluster Report: rs9409929, 2006.
37. Jurutka P.W., Remus L.S., Whitfield G.K., Thompson P.D., Hsieh J.C., Zitzer H., Tavakkoli P., Galligan M.A., Dang H.T., Haussler C.A., Haussler M.R. The polymorphic N terminus in human vitamin D receptor isoforms influences transcriptional activity by modulating interaction with transcription factor IIB. Mol. Endocrinol. 2000, 14(3):401-420.